About the Event
In this session, Dr Kilian Kelly will present on Cynata Therapeutics’s experience in achieving global reach and partnering. Kilian will provide a first-hand account of Cynata’s pathway to license agreement with FUJIFILM for an allogeneic iPS-derived cell therapy for serious complications following bone marrow transplants.
What made Cynata’s approach so successful? And what were the challenges and obstacles they had to navigate to secure a global partnership?